A new study published in the journal of Arthritis & Rheumatology showed that interstitial lung disease (ILD) can occur in ...

Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for pulmonary diseases, particularly pulmonary arterial hypertension (PAH) and pulmonary hypertension ...

These compelling results support advancing the development of nintedanib DPI for patients living with IPF, a chronic and progressive fibrotic lung disease with limited treatment options,” said Michael ...

RILD in NHL patients presents as lung disease, organizing pneumonia, and nonspecific interstitial pneumonia, with 179 ...

Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and ...

Third Quarter 2024 and Subsequent Period Highlights Third Quarter 2024 Financial Highlights and Cash Position About Efzofitimod Efzofitimod is a first-in-class biologic immunomodulator in clinical ...

The following is a summary of “A modified Delphi exercise in physician-perceived risk factors for drug-induced pneumotoxicity ...

There will also be themed networking sessions, including “Meet the Editors,” where participants can discuss scientific publishing with editors from leading rheumatic disease journals. Manno also ...

Kil's inspiring journey highlights the power of organ donation and the exceptional care provided by University of Utah Health. After being diagnosed with Interstitial Lung Disease, Kil faced a ...

The Pulmonary Fibrosis Foundation (PFF), the nation's leading pulmonary fibrosis (PF) research, education and advocacy organization, today announced that Wayne Pan, MD, PhD, MBA, has been elected as ...

Although Utahns do not smoke tobacco at the rate of Americans in most states, it doesn’t mean they are not vulnerable to lung ...

There is a bidirectional association for rheumatoid arthritis (RA) and interstitial lung disease (ILD), according to a study ...